DUCENTIS BIOTHERAPEUTICS LTD.Active

Company number 09307415Private limited companyIncorporated 2014

Key figures

−£5,949,214+24.8%
Net assets 2025
-10 m-7.5 m-5 m-2.5 m02.5 m2019/202020/212021/22202320242025

DUCENTIS BIOTHERAPEUTICS LTD. does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m2019/202020/212021/22202320242025
Filed accounts2019/20–2025
2020/212021/22202320242025
Profit for the year-1,402,959-3,206,316-3,215,084-7,839,323-5,937,214
Cash at bank and in hand624,32326,9904,0170—
Total assets965,14028,604110,7250—
Total liabilities1,623,184781,0283,321,2017,912,0365,949,214
Net assets / total equity-657,424-752,424-3,210,476-7,912,036-5,949,214
Average number of employees62230

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DUCENTIS BIOTHERAPEUTICS LTD.

Company

DUCENTIS BIOTHERAPEUTICS LTD. is a private limited company registered with Companies House under company number 09307415. It was incorporated on 12 Nov 2014. Its status is active. The registered office is in Bristol (BS1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Loss for the year was £5,937,214. Net assets were −£5,949,214, up 24.8% on the previous year. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2025).

Control and charges

One person with significant control is registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 10 Mar 2027.